Skip to content

What has been tested?#

Use this page to choose a check and understand what its result means. For an explanation of the method, start with the visual walkthrough. For a working installation, run the measured CAMPI example.

Four kinds of evidence#

Question Evidence you can inspect What it supports What it leaves open
Does the code follow its declared rules? Python/Rust tests and CI; worked grouping example Checked input handling, deterministic rules, sequence compatibility and accounting A correct implementation can still have scientific limitations
Can I run the workflow? CAMPI example, its expected results and your own VALIDATION.json; Docker checks Installation and execution on the supplied small measured inputs Full-acquisition resource needs and performance on your study
What happened on measured study data? Dated acceptance experiment: 20 FastaLake acquisitions plus 10 matched-metagenome searches Execution, descriptive recovery, overlap and quantitative variation in that declared subset A general advantage across cohorts or an isolated causal effect of curation
How reliable are the biological identifications? Search configuration and confidence fields; error-control framework; study-specific control analyses Explicit search acceptance and the evidence needed to evaluate stronger claims Whole-workflow calibration, unique biological origins and study-group FDR are not established by the checks above

These are different questions. Passing a test or reproducing a matrix is useful evidence for its stated purpose; neither is an independent calibration experiment.

A reproducible starting point#

The distributed CAMPI teaching example uses two measured acquisition windows. It includes the spectra, predictions, reference, runner and expected results. You can inspect every stage and retain the exact commands and input identities.

  1. Run the example.
  2. Check VALIDATION.json and the process exit status.
  3. Open the selected FASTA, peptide evidence and group matrix.
  4. Follow a contribution using the aggregation walkthrough.
  5. Pilot one representative full acquisition before choosing resources for a study.

The cropped example teaches execution and output interpretation. Its numbers are not full-run abundance estimates or a benchmark of de novo model accuracy. Resource measurements describe specific workloads, not guaranteed maximum requirements.

Questions to carry into a scientific study#

Question Why it matters Evidence that would address it
Does selecting candidates using the same acquisition affect error calibration? The subsequent search is conditional on an adaptively selected database Controls with justified absence/exchangeability assumptions and designs separating construction from evaluation
How does reliability vary with peptide length? Shorter strings are less specific, and search populations influence confidence estimation Length-resolved controls; clearly distinguish a subset of an existing search from a new search with a different minimum length
Does a group have a unique protein, species or functional origin? Several reference sequences can explain the same peptide evidence Full local memberships, sequence support, annotation provenance and appropriate ambiguity/sensitivity analyses
Will results transfer to a new cohort or predictor? Reference content, acquisition quality and prediction errors can change Held-out studies with declared inputs and paired gains as well as losses
Are missing quantities evidence of biological absence? Sampling, selection, search acceptance and quantification can each produce missingness Acquisition-level evidence and a separately justified downstream missing-data model

The error-control page explains the statistical scope.

Additional discoveries need a separate check#

A peptide q-value threshold applies to the population for which the search estimated it. The identities added relative to another search form a selected subset; they do not automatically inherit that population's error guarantee. Report additional identities, reciprocal losses and shared identities separately, using a matched comparator and the same declared acceptance rule. Identification counts at a nominal threshold are not verified gains at matched true error rates.

Database selection can remove a sequence that would otherwise compete to explain a spectrum. Retaining more candidates, using a stricter q threshold, or increasing the minimum peptide length does not by itself establish calibration. A proposed change needs evaluation of both error and retained true yield, followed by fresh evidence that was not used to choose the change. An empty accepted set is abstention and supplies no empirical precision information about recovered identities. Simulation truth can diagnose a failure mechanism; representative measured controls and justified control comparability remain separate requirements.

The output contract explains the reporting scope. The manuscript reproduction guide keeps paper settings and producing versions distinct from a current software run.

Keep the historical record interpretable#

The earlier validation page is retained as the September 2026 acceptance record, including its measurements, adverse observations, failed attempts, retries and limitations. Its ten-acquisition HSTOOL subset is not the later 58-acquisition reporting study. Its test counts and dependency audit describe that dated build, not every later commit. Use the CI result for the exact revision you run.

For reproduction, record the revision, input identities, searched FASTAs, search settings, acquisition roster and grouping/quantification policy. Report a study lists the files to preserve.

Help improve the method#

A useful collaborator report names the claim or behavior, the exact inputs and revision, what was observed, and a small shareable reproducer when possible. Failures and unexpected results are useful. Keep participant data out of public issues; provide an approved minimal example. See contributing for the development workflow.